09-29 C-Rad and SeeTreat develop joint platform for radiation therapy FW
09-29 C-RAD and SeeTreat partner to co-develop personalised radiotherapy for every patient in every clinic AQ
09-29 C-Rad enters partnership with SeeTreat FW
09-28 C-Rad presents product news and expanded interoperability at ASTRO FW
09-28 C-RAD brings accessible SGRT, expanded interoperability and a first look at the next-generation workflow platform to ASTRO 2026 AQ
07-20 Pareto Securities raises C-Rad price target to 45 kronor (36), reiterates buy FW
07-17 C-Rad AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
07-17 C-Rad increased revenue and improved operating profit FW
07-17 C RAD : Interim Report Q2'26 PU
07-17 C-RAD's Interim Report Q2’26 AQ
06-16 C-Rad executive purchases shares worth nearly SEK 0.4m FW
06-15 C-Rad COO Johan Danielsson purchases shares worth SEK 0.25m FW
06-10 C-Rad CFO Linda Frölén buys shares worth SEK 0.75 million FW
05-15 C-Rad and SeeTreat launch partnership for personalized radiotherapy FW
05-15 C-Rad, SeeTreat partner to deliver radiotherapy RE
05-15 C-RAD and SeeTreat partner to deliver personalised radiotherapy for every patient AQ
05-15 C-Rad and Seetreat Partner to Deliver Personalised Radiotherapy for Every Patient CI
05-13 C-RAD marks its new chapter at ESTRO 2026 with clinician-driven SGRT advances AQ
05-07 Pareto Securities raises C-Rad price target to SEK 36 (30), reiterates Buy FW
05-06 Affärsvärlden issues buy rating for C-Rad FW
05-06 C-Rad AB Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
05-06 C Rad Q1 adjusted EBIT SEK 22 mln RE
05-06 C-Rad reports revenue decline but posts higher operating profit FW
05-06 C-RAD's Interim Report Q1’26 AQ
04-28 Pareto Securities cuts C-Rad price target to SEK 30 (35), reiterates Buy FW
No results match your criteria